Story perspectives

CDC Reports 3,437 Candida auris Cases, Rising Drug Resistance

8/5/2026

Summary

CDC Reports Candida

CDC reported 3,437 Candida auris cases in 27 states in 2026, with Texas at 706 cases as of July 18.
Dr. Tom Chiller, CDC Mycotic Diseases chief, said early detection and infection control are essential.
Dr. Nathan Wiederhold, director of the Fungus Testing Laboratory, warned many strains resist azoles and some resist amphotericin B.
CDC estimates up to 60 % fatality, while researchers place overall mortality between 30 % and 60 %.

Summary

CDC Urges Testing

CDC urges labs to add testing when Candida auris cannot be identified or similar yeasts appear, because labs often misidentify it and colonized patients are asymptomatic, so treatment guidance applies only to confirmed infections.
For resistant cases, CDC says patients can obtain investigational antifungals via programs.
A rise in unidentified Candida or urine isolates—organisms that grow at 104-108 °F and rarely form germ tubes—should raise suspicion of C. auris.

1 of 2

CDC Reports Candida

CDC reported 3,437 Candida auris cases in 27 states in 2026, with Texas at 706 cases as of July 18.
Dr. Tom Chiller, CDC Mycotic Diseases chief, said early detection and infection control are essential.
Dr. Nathan Wiederhold, director of the Fungus Testing Laboratory, warned many strains resist azoles and some resist amphotericin B.
CDC estimates up to 60 % fatality, while researchers place overall mortality between 30 % and 60 %.

1 / 2